Be Vape Free Curriculum for Preventing Vaping
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if an online program can help middle and high school students avoid vaping and tobacco use. It will test the effectiveness of the Stanford Vaping Prevention curriculum in changing students' attitudes and intentions about e-cigarettes and in reducing tobacco use. Participants will receive either this vaping prevention curriculum or an alternative/no education to compare outcomes. The trial suits students in schools already participating in the study and receiving health education. As an unphased trial, this study allows students to contribute to important research that could shape future health education programs.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that the Stanford Vaping Prevention curriculum is safe for students?
Research has shown that the Stanford Vaping Prevention curriculum is safe for students. Schools use this program to teach about the dangers of vaping, helping students understand e-cigarettes better and learn how to refuse them.
Studies have found that programs like this enhance students' knowledge about vaping and alter their perceptions. They also help reduce the belief that e-cigarettes can relieve stress. These findings suggest the curriculum is well-received and does not cause any negative effects.
As a teaching tool, not a medicine, the curriculum does not have side effects like drugs. Its goal is to educate, making it a safe choice for schools.12345Why are researchers excited about this trial?
Researchers are excited about the Stanford Vaping Prevention curriculum because it offers a fresh, educational approach to tackling the rise in youth vaping. Unlike traditional methods that might focus on cessation or punitive measures, this curriculum is designed to prevent vaping by educating students on the health risks and social influences associated with vaping. It engages students in a proactive way, using evidence-based strategies developed by experts in adolescent behavior and health education. This focus on prevention rather than treatment could be key to reducing vaping rates among young people before they start.
What evidence suggests that the Stanford Vaping Prevention curriculum is effective for preventing vaping?
Research has shown that the Stanford Vaping Prevention curriculum, which participants in this trial may receive, can help middle and high school students avoid using e-cigarettes. One study found that after a short school program, students knew more about e-cigarettes and improved their ability to refuse them. They also showed less interest in using these products. Another study found that students who took a five-session course gained more knowledge about the addictive nature of e-cigarettes and were less inclined to try them. These findings suggest that the curriculum effectively changes students' attitudes and perceptions about vaping.12467
Who Is on the Research Team?
Bonnie Halpern-Felsher, Ph.D.
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for middle and high school students who are currently receiving health education at schools that have chosen to participate in the study. There are no specific exclusion criteria, so all students in these settings can potentially join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pilot Phase
Stanford vaping prevention curriculum is administered as a pilot arm preceding the main experimental intervention
Randomized Phase
Participants receive either the Stanford vaping prevention curriculum or another curriculum/no vaping prevention education
Follow-up
Participants are monitored for changes in e-cigarette use and intention to use e-cigarettes
What Are the Treatments Tested in This Trial?
Interventions
- Stanford Vaping Prevention curriculum
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator